NCT01071876View on ClinicalTrials.gov

BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS

PHASE3CompletedINTERVENTIONAL

Enrollment

244

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Obstructive Sleep ApneaExcessive Daytime Sleepiness

Interventions

DRUG

BF2.649

1 capsule in the morning before breakfast

DRUG

Placebo

1 capsule in the morning before breakfast

Trial Locations (1)

Unknown

CHU Grenoble, Grenoble

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bioprojet

OTHER